Statistics for State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures

Total visits

views
State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures 0

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0